Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another Story

Rayonier Advanced Materials (RYAM) reported Q2 net sales of $376M, up 18% QoQ and 11% YoY, with a narrowed loss of $33M. High Purity Cellulose segment saw a 21% YoY price increase, boosting operating income by 45%. However, Cellulose Specialties volume fell 23% YoY. Management maintains a 2026 outlook for positive free cash flow and targets Q4 2026 for a strategic review conclusion.

Original reporting
Published Sep 11, 2026, 3:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 3:36 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another Story — source image
Decision brief

The 30-second read

$RYAMNeutralMed
01

Why it matters

Earnings beat on pricing may attract short covering, but volume weakness and debt levels could sustain bearish pressure.

02

Market read

Earnings release provides fresh data for traders; strategic review timing adds a catalyst for near‑term price movement.

03

What to watch

Potential upside from Altamaha Green Energy project and upcoming strategic review outcome not fully priced in.

Relevance 7/10Novelty 8/10Timing: post‑market August 4 release

Background

Rayonier Advanced Materials reported Q2 results, showing improved pricing but lower volumes and high leverage.

Company-level read

Ticker impact

$RYAMNeutralMedium confidence
Context

Q2 2026 earnings released with 18% sales growth, narrowed loss, and pricing gains in Cellulose Specialties.

Expected impact

Potential upside if review yields positive guidance; downside risk if leverage concerns persist.

Evidence & confidence

Earnings beat on pricing but volume weakness and high leverage suggest mixed outlook; market reaction will hinge on strategic review.

Market effects

Highlights pricing strength in high‑purity cellulose, may benefit peers in specialty chemicals.

U.S. pulp and paper sector faces pressure from oversupply; Asian high‑yield pulp market remains soft.

Limited to specialty cellulose niche; broader market impact modest.

Counterpoint

Despite pricing gains, the sharp volume decline and rising leverage could signal deeper demand weakness.

Key entities

  • Daniel Krawczyk

    CEO who highlighted strategic review timeline.

Related articles

$RYAMMedAI 8/10

Rayonier Advanced Materials Q3 Earnings Call Highlights

Rayonier Advanced Materials (RYAM) reported Q3 net sales of $383M, up 2% sequentially and 8% YoY. Adjusted EBITDA rose to $52M. High Purity Cellulose sales increased, while Paperboard & High Yield Pulp sales declined. The company is focusing on its Cellulose Specialties franchise and expects positive free cash flow for 2026, subject to certain conditions.

$RYAMMed

Rayonier Advanced Materials Inc (RYAM) Q3 2026 Earnings Call Highlights: HPC Segment

Rayonier Advanced Materials (RYAM) reported Q3 2026 net sales of $383M, up 2% sequentially and 8% YoY. Adjusted EBITDA rose 30% to $52M. CEO Dan Kraupchak discussed strategic plans, including optimizing production mix and pursuing longer-term customer agreements. CFO Marcus Moltner noted $4M energy credits and $2M tariff-related costs. CS volumes are expected to exit the year at ~100,000 metric tons per quarter. Liquidity stands at $143M, with positive adjusted free cash flow of $2M YTD.

$RYAMHighAI 8/10

Rayonier Advanced Materials 3Q 2026: Revenue $382.51M, Net income ($229.77M), EPS ($3.4) — 10-Q Summary

Rayonier Advanced Materials reported 3Q 2026 revenue of $382.51M, up 8.4% YoY, but net loss widened to $229.77M. EPS loss was $3.4. Sales growth was driven by higher cellulose specialties pricing and increased volumes. The company idled uneconomic operations at Temiscaming and is targeting CS-focused production growth. A strategic review is expected to complete in Q1 2027.

$RYAMMed

RYAM Reports Third Quarter 2026 Results

RAYONIER ADVANCED MATERIALS INC. (RYAM) filed an SEC Form 8-K — Results of Operations and Financial Condition. RYAM Reports Third Quarter 2026 Results Delivers 30% sequential growth in Adjusted EBITDA Temiscaming production economically idled following U.S. tariffs • Loss from Continuing Operations of $229 million adjusted for non-cash impairments of $221 million was $8 million, a 60% seq

$RYAMHighAI 8/10

RYAM Reports Third Quarter 2026 Results

Rayonier Advanced Materials (RYAM) reported Q3 2026 results. HPC income rose to $29M with Adjusted EBITDA of $44M, while Temiscaming operations were idled. Consolidated Adjusted EBITDA was $52M, including tariff costs. The company aims to conclude its strategic review in Q1 2027. Net sales were $383M, with HPC at $313M and Paperboard & High Yield Pulp at $70M. Operating loss was $196M, including non-cash impairments. Year-to-date Adjusted Free Cash Flow was $66M.

$RYAMMedAI 8/10

Rayonier (RYAM) Q2 2026 Earnings Call Transcript

Rayonier Advanced Materials (RYAM) reported Q2 2026 net sales of $376 million, up 18% sequentially and 11% year over year. Adjusted EBITDA rose to $40 million. Loss from continuing operations was $33 million. Management reiterated full-year positive free cash flow guidance and said its strategic alternatives review will conclude in Q4 2026.